Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Antagonist Properties of a Phosphono Isoxazole Amino Acid at Glutamate R1–4 (R,S)-2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptor Subtypes

Philip Wahl, Charlotte Anker, Stephen F. Traynelis, Jan Egebjerg, Jesper S. Rasmussen, Povl Krogsgaard-Larsen and Ulf Madsen
Molecular Pharmacology March 1998, 53 (3) 590-596; DOI: https://doi.org/10.1124/mol.53.3.590
Philip Wahl
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Anker
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen F. Traynelis
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Egebjerg
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesper S. Rasmussen
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Povl Krogsgaard-Larsen
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulf Madsen
1 2 3 4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 53 no. 3 590-596
DOI 
https://doi.org/10.1124/mol.53.3.590
PubMed 
9495827

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received July 18, 1997
  • Accepted November 5, 1997
  • Published online March 1, 1998.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Philip Wahl1,
  2. Charlotte Anker1,
  3. Stephen F. Traynelis2,
  4. Jan Egebjerg3,
  5. Jesper S. Rasmussen3,
  6. Povl Krogsgaard-Larsen4, and
  7. Ulf Madsen4
  1. 1Department of Molecular Pharmacology, Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Maaloev, Denmark (P.W., C.A.), 2Department of Pharmacology, Emory University, Atlanta, GA 30322-3090, USA (S.F.T.), 3Department of Molecular Genetics, Novo Nordisk A/S, DK-2880 Bagsværd, Denmark (J.E., J.S.R.) and 4Department of Medicinal Chemistry, The Royal Danish School of Pharmacy, DK-2100 Copenhagen, Denmark (P.K.-L., U.M.)
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 1999 to September 2023

AbstractFullPdf
Jan 1999111
Feb 1999010
Mar 1999212
Apr 1999121
May 1999025
Jun 1999133
Jul 1999124
Aug 1999134
Sep 1999210
Oct 1999174
Nov 1999076
Dec 1999070
Jan 2000066
Mar 2000023
Apr 2000102
May 2000031
Jun 2000013
Jul 2000112
Aug 2000032
Sep 2000234
Oct 2000268
Nov 2000120
Dec 2000022
Jan 2001033
Feb 2001031
Mar 2001024
Apr 2001134
May 2001012
Jun 2001133
Jul 2001024
Aug 2001242
Sep 2001063
Oct 2001052
Nov 2001045
Dec 2001034
Jan 2002097
Feb 2002150
Mar 2002110
Apr 2002021
May 2002035
Jun 2002032
Jul 2002042
Aug 2002004
Sep 2002024
Oct 2002133
Nov 2002144
Dec 2002123
Jan 2003141
Feb 2003020
Mar 20030610
Apr 2003020
May 2003259
Jun 2003121
Jul 20039120
Aug 20038224
Sep 20039112
Oct 20033184
Nov 20036217
Dec 20038134
Jan 200410278
Feb 20047154
Mar 200411313
Apr 200412190
May 200411111
Jun 200415285
Jul 200414191
Aug 2004790
Sep 200411110
Oct 20047182
Nov 200413258
Dec 20048132
Jan 20057111
Feb 20059141
Mar 20059293
Apr 2005271
May 20052154
Jun 20057133
Jul 20052111
Aug 2005291
Sep 20052120
Oct 20054155
Nov 2005792
Dec 20054113
Jan 20065462
Feb 20063263
Mar 20064290
Apr 2006052
May 2006181
Jun 2006130
Jul 2006261
Aug 2006231
Sep 2006224
Oct 2006384
Nov 20063105
Dec 2006141
Jan 20070125
Feb 2007652
Mar 2007092
Apr 20072133
May 20071164
Jun 2007175
Jul 2007063
Aug 20070118
Sep 20072611
Oct 2007295
Nov 2007064
Dec 2007022
Jan 2008040
Feb 200821210
Mar 2008254
Apr 2008373
May 2008250
Jun 200813156
Jul 2008113
Aug 2008431
Sep 2008560
Oct 2008610
Nov 20081035
Dec 2008120
Jan 2009143
Feb 2009242
Mar 2009046
Apr 2009045
May 2009110
Jun 2009341
Jul 2009421
Aug 2009144
Sep 2009936
Oct 2009803
Nov 2009633
Dec 2009523
Jan 2010140
Feb 2010674
Mar 2010372
Apr 2010731
May 2010272
Jun 2010142
Jul 2010394
Aug 2010193
Sep 2010261
Oct 2010535
Nov 2010353
Dec 2010644
Jan 2011331
Feb 2011258
Mar 20114411
Apr 20111910
May 2011354
Jun 2011723
Jul 20111149
Aug 2011986
Sep 20111510
Oct 2011777
Nov 20115813
Dec 201110102
Jan 2012796
Feb 2012488
Mar 20129128
Apr 20121295
May 20121077
Jun 2012857
Jul 20124129
Aug 2012885
Sep 201212511
Oct 2012141211
Nov 2012464
Dec 2012889
Jan 20131384
Feb 20131367
Mar 2013566
Apr 20131275
May 2013856
Jun 2013121
Jul 2013321
Aug 2013519
Sep 2013644
Oct 2013828
Nov 2013632
Dec 20131849
Jan 2014323
Feb 2014531
Mar 2014203
Apr 2014277
May 2014578
Jun 2014911
Jul 2014613
Aug 2014243
Sep 20141046
Oct 20146110
Nov 20148101
Dec 2014876
Jan 2015151
Feb 2015221
Mar 2015910
Apr 2015741
May 2015670
Jun 2015843
Jul 20151792
Aug 2015672
Sep 2015110
Oct 2015100
Nov 2015411
Dec 2015044
Jan 2016523
Feb 2016531
Mar 2016619
Apr 2016441
May 2016201
Jun 2016031
Jul 2016172
Aug 2016320
Sep 2016432
Oct 2016921
Nov 2016031
Dec 2016052
Jan 2017062
Feb 2017161
Mar 2017082
Apr 2017313
May 20171141
Jun 2017373
Jul 20170114
Aug 20172133
Sep 20172134
Oct 20172112
Nov 20173154
Dec 2017482
Jan 20184123
Feb 2018372
Mar 2018574
Apr 20183165
May 20181154
Jun 20180154
Jul 2018183
Aug 2018030
Sep 2018274
Oct 20181124
Nov 2018062
Dec 20181831
Jan 2019600
Feb 20191032
Mar 20191000
Apr 20191600
May 20191400
Jun 20191224
Jul 20191500
Aug 20191900
Sep 2019900
Oct 2019731
Nov 20191820
Dec 20192200
Jan 20201400
Feb 20201111
Mar 2020600
Apr 2020300
May 2020220
Jun 2020500
Jul 20201000
Aug 2020402
Sep 2020210
Oct 2020400
Nov 2020610
Dec 20201210
Jan 2021510
Feb 2021843
Mar 20211020
Apr 2021542
May 20211142
Jun 2021520
Jul 2021720
Aug 2021320
Sep 20211310
Oct 2021710
Nov 2021610
Dec 20211720
Jan 20221110
Feb 2022620
Mar 2022421
Apr 2022710
May 2022310
Jun 2022521
Jul 20221010
Aug 20221420
Sep 2022220
Oct 20221230
Nov 2022210
Dec 2022210
Jan 2023340
Feb 2023240
Mar 2023730
Apr 2023910
May 2023720
Jun 2023830
Jul 20231020
Aug 2023310
Sep 2023410

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 53 (3)
Molecular Pharmacology
Vol. 53, Issue 3
1 Mar 1998
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antagonist Properties of a Phosphono Isoxazole Amino Acid at Glutamate R1–4 (R,S)-2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptor Subtypes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Antagonist Properties of a Phosphono Isoxazole Amino Acid at Glutamate R1–4 (R,S)-2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptor Subtypes

Philip Wahl, Charlotte Anker, Stephen F. Traynelis, Jan Egebjerg, Jesper S. Rasmussen, Povl Krogsgaard-Larsen and Ulf Madsen
Molecular Pharmacology March 1, 1998, 53 (3) 590-596; DOI: https://doi.org/10.1124/mol.53.3.590

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Antagonist Properties of a Phosphono Isoxazole Amino Acid at Glutamate R1–4 (R,S)-2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptor Subtypes

Philip Wahl, Charlotte Anker, Stephen F. Traynelis, Jan Egebjerg, Jesper S. Rasmussen, Povl Krogsgaard-Larsen and Ulf Madsen
Molecular Pharmacology March 1, 1998, 53 (3) 590-596; DOI: https://doi.org/10.1124/mol.53.3.590
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics